Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network.

Guirguis-Blake J, Keppel GA, Holmes J, Force RW, Kriegsman W, Baldwin LM.

Fam Pract. 2018 Sep 18;35(5):589-594. doi: 10.1093/fampra/cmy001.

2.

Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non-Small-cell Lung Cancer in a US Community Oncology Setting.

Weiss J, Force RW, Pugmire BA, Peterson T, Faria C, Margunato-Debay S, Patel MB.

Clin Lung Cancer. 2017 Jul;18(4):372-380.e1. doi: 10.1016/j.cllc.2016.12.008. Epub 2016 Dec 22.

PMID:
28117221
3.

Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial.

Linz PE, Lovato LC, Byington RP, O'Connor PJ, Leiter LA, Weiss D, Force RW, Crouse JR, Ismail-Beigi F, Simmons DL, Papademetriou V, Ginsberg HN, Elam MB.

Diabetes Care. 2014;37(3):686-93. doi: 10.2337/dc13-0790. Epub 2013 Dec 2.

4.

Barriers and facilitators to evidence-based blood pressure control in community practice.

Robins LS, Jackson JE, Green BB, Korngiebel D, Force RW, Baldwin LM.

J Am Board Fam Med. 2013 Sep-Oct;26(5):539-57. doi: 10.3122/jabfm.2013.05.130060.

5.

Contraceptive methods and informed consent among women receiving medications with potential for adverse fetal effects: a Washington, Wyoming, Alaska, Montana, Idaho (WWAMI) region study.

Force RW, Keppel GA, Guirguis-Blake J, Gould DA, Vincent C, Chunchu K, Monger RM, Holmes JT, Cauffield J, Baldwin LM.

J Am Board Fam Med. 2012 Sep-Oct;25(5):661-8.

6.

Variation in refill protocols and procedures in a family medicine residency network.

Guirguis-Blake J, Keppel GA, Force RW, Cauffield J, Monger RM, Baldwin LM.

Fam Med. 2012 Sep;44(8):564-8.

7.

Developing a practice-based research network by integrating quality improvement: challenges and ingredients for success.

Baldwin LM, Keppel GA, Davis A, Guirguis-Blake J, Force RW, Berg AO.

Clin Transl Sci. 2012 Aug;5(4):351-5. doi: 10.1111/j.1752-8062.2012.00405.x. Epub 2012 Mar 27.

8.

Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial.

Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, Josse RG, Schnall AM, Simmons DL, Hue TF, Palermo L, Hamilton BP, Green JB, Atkinson HH, O'Connor PJ, Force RW, Bauer DC.

Diabetes Care. 2012 Jul;35(7):1525-31. doi: 10.2337/dc11-2184.

9.
10.

Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone.

Wilkinson JJ, Force RW, Cady PS.

Pharmacotherapy. 2004 Aug;24(8):978-86.

PMID:
15338846
11.

Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.

Barzilay JI, Davis BR, Bettencourt J, Margolis KL, Goff DC Jr, Black H, Habib G, Ellsworth A, Force RW, Wiegmann T, Ciocon JO, Basile JN; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2004 Mar;6(3):116-25.

12.

Tubes for otitis media do not improve developmental outcomes.

Pettinger TK, Force RW.

J Fam Pract. 2003 Dec;52(12):939-40. No abstract available.

PMID:
14653978
13.
14.

Ambulatory care increased vitamin B12 requirement associated with chronic acid suppression therapy.

Force RW, Meeker AD, Cady PS, Culbertson VL, Force WS, Kelley CM.

Ann Pharmacother. 2003 Apr;37(4):490-3.

PMID:
12659601
15.
16.

Detriments of tPA for acute stroke in routine clinical practice.

Novak BL, Force RW.

J Fam Pract. 2003 Feb;52(2):95-6.

PMID:
12585980
17.
18.

Confessions of a fly-fisherman and sometime drug company courtesan.

Force RW.

Pharmacotherapy. 2002 Feb;22(2):269-70. No abstract available.

PMID:
11837565
19.

Comment: accuracy of store-based blood pressure monitors.

Hoffman G, Force RW.

Ann Pharmacother. 2001 Dec;35(12):1676. No abstract available.

PMID:
11793647
20.

Suspected tegenaria agrestis envenomation.

Sadler MA, Force RW, Solbrig RM, Sommer S.

Ann Pharmacother. 2001 Nov;35(11):1490-1. No abstract available.

PMID:
11724105
21.

Isolated elevation of alkaline phosphatase level associated with rosiglitazone.

Hachey DM, O'Neil MP, Force RW.

Ann Intern Med. 2000 Nov 7;133(9):752. No abstract available.

PMID:
11074926
22.

Lessons from the fenfluramines: antiobesity medications are frequently misused.

Lawless-Liday C, Force RW.

Ann Pharmacother. 2000 Mar;34(3):404. No abstract available.

PMID:
10917392
23.

Indinavir crystalluria in an HIV-positive man.

Hachey DM, Force RW, Schott J, O'Leary-Jepsen E.

Ann Pharmacother. 2000 Mar;34(3):403. No abstract available.

PMID:
10917391
24.

Cost-effectiveness analysis of management of sore throats in children.

Pribyl J, Force RW.

J Fam Pract. 1999 Nov;48(11):913-4. No abstract available.

PMID:
10907633
25.

Oseltamivir for flu prevention.

Johnson JM, Force RW.

J Fam Pract. 2000 Feb;49(2):183-4. No abstract available.

PMID:
10718698
26.

Pharmacokinetics of fluconazole in young infants.

Nahata MC, Tallian KB, Force RW.

Eur J Drug Metab Pharmacokinet. 1999 Apr-Jun;24(2):155-7.

PMID:
10510743
27.

Do bedrails decrease falls in hospitalized patients?

Schott J, Force RW.

J Fam Pract. 1999 Aug;48(8):579. No abstract available.

PMID:
10496631
28.

The effect of ACE inhibitors on cardiovascular morbidity and mortality.

Hachey D, Force RW.

J Fam Pract. 1999 Jun;48(6):414-5. No abstract available.

PMID:
10386477
29.

Positive impact of a follow-up phone call to community pharmacies in a medicaid drug utilization program.

Culbertson VL, Force RW, Cady PS, Force WS.

Ann Pharmacother. 1999 May;33(5):541-7.

PMID:
10369614
30.

Nebulized ipratropium for children with acute asthma.

Hachey D, Force RW.

J Fam Pract. 1999 Jan;48(1):12-3. No abstract available.

PMID:
9934374
31.

Tamoxifen for breast cancer prevention.

Force RW.

J Fam Pract. 1998 Nov;47(5):336-7. No abstract available.

PMID:
9834765
32.

Sildenafil for erectile dysfunction.

Lawless C, Force RW.

J Fam Pract. 1998 Aug;47(2):97-8. No abstract available.

PMID:
9722794
33.

Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR.

Am J Obstet Gynecol. 1998 Feb;178(2):203-11. Review.

PMID:
9500475
34.

Reducing cardiovascular morbidity and mortality with the statins.

Force RW.

J Am Board Fam Pract. 1998 Jan-Feb;11(1):57-62. Review. No abstract available.

PMID:
9456448
35.

Pramipexole for Parkinson's disease.

Ting RM, Force RW.

J Fam Pract. 1998 Jan;46(1):19-20. No abstract available.

PMID:
9451363
36.

Lowering the rate of antibiotic resistance.

Rohner CD, Force RW.

J Fam Pract. 1997 Nov;45(5):374. No abstract available.

PMID:
9374954
37.

Psychotic episode after melatonin.

Force RW, Hansen L, Bedell M.

Ann Pharmacother. 1997 Nov;31(11):1408. No abstract available.

PMID:
9391704
38.

Penciclovir cream for herpes simplex labialis.

Lawless C, Force RW.

J Fam Pract. 1997 Aug;45(2):105-6. No abstract available.

PMID:
9267367
39.

Metformin-associated nonketotic metabolic acidosis.

Jurovich MR, Wooldridge JD, Force RW.

Ann Pharmacother. 1997 Jan;31(1):53-5.

PMID:
8997466
40.

Prevention of NSAID-induced ulcers.

Lawless C, Force RW.

J Fam Pract. 1996 Sep;43(3):239-40. No abstract available.

PMID:
8797749
41.

Home treatment of deep venous thrombosis.

Force RW.

J Fam Pract. 1996 Jun;42(6):566-7. No abstract available.

PMID:
8656163
42.

Heparin-induced thrombocytopenia.

Borkowski DA, Force RW.

Am J Health Syst Pharm. 1995 Nov 15;52(22):2528, 2535-6. No abstract available.

PMID:
8590236
43.

Topical ciprofloxacin for otorrhea after tympanostomy tube placement.

Force RW, Hart MC, Plummer SA, Powell DA, Nahata MC.

Arch Otolaryngol Head Neck Surg. 1995 Aug;121(8):880-4.

PMID:
7619414
44.

Fluconazole concentrations in breast milk.

Force RW.

Pediatr Infect Dis J. 1995 Mar;14(3):235-6. No abstract available.

PMID:
7761190
46.

Palatability of 14 over-the-counter antacids.

Bahal-O'Mara N, Force RW, Nahata MC.

Am Pharm. 1994 Jan;NS34(1):31-5.

PMID:
8166033
47.

Loracarbef: a new orally administered carbacephem antibiotic.

Force RW, Nahata MC.

Ann Pharmacother. 1993 Mar;27(3):321-9. Review.

PMID:
8453172
48.

Haemophilus influenzae type B conjugate vaccines.

Force RW, Lugo RA, Nahata MC.

Ann Pharmacother. 1992 Nov;26(11):1429-40. Review.

PMID:
1477450
49.

Effect of histamine H2-receptor antagonists on vitamin B12 absorption.

Force RW, Nahata MC.

Ann Pharmacother. 1992 Oct;26(10):1283-6.

PMID:
1358279
50.

Comment: Warfarin and the International Normalized Ratio.

Force RW, Roush MK, Bussey HI.

Ann Pharmacother. 1992 Mar;26(3):430-1. No abstract available.

PMID:
1554967

Supplemental Content

Loading ...
Support Center